29265-85-8

Basic information

• Product Name: Benzene, 1,1'-ethenylidenebis[3-bromo-
• CAS NO: 29265-85-8
• Molecular Formula: C14H10Br2
• Molecular Weight: 338.041
• Mol File: 29265-85-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzene, 1,1'-ethenylidenebis[3-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1,1'-ethenylidenebis[3-bromo-(29265-85-8)
• EPA Substance Registry System: Benzene, 1,1'-ethenylidenebis[3-bromo-(29265-85-8)

Safety Data

• Hazardous Substances Data: 29265-85-8(Hazardous Substances Data)

Upstream product

• 145343-68-6 1,1-bis(3-bromophenyl)ethanol 
• 25032-74-0 3,3'-dibromobenzophenone 
• 19493-09-5 Methylenetriphenylphosphorane 
• 108-36-1 1,3-dibromobenzene 
• 2142-63-4 1-(3-Bromophenyl)ethanone 
• 1779-49-3 Methyltriphenylphosphonium bromide 

Downstream Products

• 145343-65-3 1,1-bis<3-(N-oxy-tert-butylamino)phenyl>ethylene 
• 144791-90-2 1,1'-bis(3-azidophenyl)ethene 
• 145343-70-0 1,1-bis<3-(N-hydroxy-tert-butylamino)phenyl>ethylene 
• 10605-51-3 1,1-Bis(m-Cyanophenyl)-ethylen 

Relevant articles and documents

Discovery of 6,11-ethano-12,12-diaryl-6,11-dihydrobenzo[b]quinolizinium cations, a novel class of N-methyl-D-aspartate antagonists

6,11-Ethano-12,12-diaryl-6,11-dihydrobenzo[b]quinolizinium cations 8, a novel class of N-methyl-D-aspartate (NMDA) antagonists acting at the phencyclidine site, have been identified. Structure-activity relationship studies around the lead compound 8a led

Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof

Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment of neurodegenerative disorders or neurotoxic injuries utilizing them, wherein the substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts have the formula: STR1 wherein: R1, R2, R3, R4, R5, R6, R7, X and p are as defined in the specification.